Zdenek K.
- Country
- Czechia
- Department
- 120302: Klinika hematoonkologie
Research Overview
- A Phase 2a/2b, Open-label, Proof of Concept (Phase 2a) and Open-label (Phase 2b), Multicenter, Efficacy, and Safety Study of AG-946in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes
- Phase 3 Evaluation of Venetoclax and Azacitidine Post-Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients
- Evaluation of Venetoclax and Azacitidine Combination Therapy Versus Placebo and Azacitidine in Treatment-Naïve Patients with Higher-Risk Myelodysplastic Syndrome
Data & Insights
Has run more than one trial at 166 of 320 partner sites.
Specializations
Myelodysplastic Syndrome Research
The investigator demonstrates extensive expertise in studying myelodysplastic syndrome (MDS), with particular focus on both higher-risk and lower-risk variants. Their research encompasses novel therapeutic approaches for managing MDS, including investigations of treatments for newly diagnosed patients.
- Higher-risk MDS therapeutic interventions
- Lower-risk MDS anemia management
- RARA-positive MDS treatment strategies
Their work involves evaluating innovative combination therapies and investigating targeted treatments for specific MDS subtypes.
Acute Myeloid Leukemia Studies
The investigator specializes in acute myeloid leukemia (AML) research, focusing on post-transplant maintenance therapy and treatment strategies for relapsed/refractory disease. Their expertise extends to evaluating various therapeutic intensities in AML treatment.
- Post-transplant maintenance approaches
- Relapsed/refractory AML management
- Novel combination therapies
Their research explores innovative treatment combinations and therapeutic strategies for different AML patient populations.
Graft-versus-Host Disease Research
The investigator's work includes studying chronic graft-versus-host disease, with particular attention to novel oral therapeutic approaches. Their research focuses on combination treatments involving corticosteroids and new pharmaceutical agents.
- Novel oral therapeutic agents
- Combination treatment strategies
- Pediatric and adult applications
Their investigations aim to advance treatment options for patients with chronic graft-versus-host disease across different age groups.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.